[2]
LERNER AB,WATSON CJ, Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). The American journal of the medical sciences. 1947 Oct;
[PubMed PMID: 20266939]
[3]
Middaugh CR,Litman GW, Atypical glycosylation of an IgG monoclonal cryoimmunoglobulin. The Journal of biological chemistry. 1987 Mar 15;
[PubMed PMID: 3102493]
[4]
Tomana M,Schrohenloher RE,Koopman WJ,Alarcón GS,Paul WA, Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis and rheumatism. 1988 Mar;
[PubMed PMID: 3358797]
[5]
Brouet JC,Clauvel JP,Danon F,Klein M,Seligmann M, Biologic and clinical significance of cryoglobulins. A report of 86 cases. The American journal of medicine. 1974 Nov;
[PubMed PMID: 4216269]
Level 3 (low-level) evidence
[6]
Terrier B,Karras A,Kahn JE,Le Guenno G,Marie I,Benarous L,Lacraz A,Diot E,Hermine O,de Saint-Martin L,Cathébras P,Leblond V,Modiano P,Léger JM,Mariette X,Senet P,Plaisier E,Saadoun D,Cacoub P, The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine. 2013 Mar;
[PubMed PMID: 23429354]
Level 3 (low-level) evidence
[7]
Musset L,Diemert MC,Taibi F,Thi Huong Du L,Cacoub P,Leger JM,Boissy G,Gaillard O,Galli J, Characterization of cryoglobulins by immunoblotting. Clinical chemistry. 1992 Jun;
[PubMed PMID: 1597004]
[8]
Aguiar MF,Faria-Janes AL,Garcia-Brandes GI,Takemi-Emori C,Ferraz MLG,Andrade LEC,de Souza AWS, Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients. Annals of hepatology. 2019 Sep - Oct;
[PubMed PMID: 31167733]
[9]
Ferri C,Greco F,Longombardo G,Palla P,Moretti A,Marzo E,Fosella PV,Pasero G,Bombardieri S, Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection. 1991 Nov-Dec;
[PubMed PMID: 1726164]
[10]
Terrier B,Marie I,Lacraz A,Belenotti P,Bonnet F,Chiche L,Graffin B,Hot A,Kahn JE,Michel C,Quemeneur T,de Saint-Martin L,Hermine O,Léger JM,Mariette X,Senet P,Plaisier E,Cacoub P, Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature. Journal of autoimmunity. 2015 Dec;
[PubMed PMID: 26320984]
Level 3 (low-level) evidence
[11]
Casato M,de Rosa FG,Pucillo LP,Ilardi I,di Vico B,Zorzin LR,Sorgi ML,Fiaschetti P,Coviello R,Laganà B,Fiorilli M, Mixed cryoglobulinemia secondary to visceral Leishmaniasis. Arthritis and rheumatism. 1999 Sep;
[PubMed PMID: 10513819]
[12]
Galli M,Invernizzi F,Chemotti M,Monti G,Gasparro MG,Caredda F,Negri C,Moroni M, Cryoglobulins and infectious diseases. La Ricerca in clinica e in laboratorio. 1986 Apr-Jun;
[PubMed PMID: 3097790]
[13]
Lazzerini PE,Cusi MG,Selvi E,Capecchi M,Moscadelli V,Migliacci N,Finizola F,Laghi-Pasini F, Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection. Joint bone spine. 2018 Jan;
[PubMed PMID: 28062379]
[14]
Hasegawa J,Hayami N,Hoshino J,Suwabe T,Sumida K,Mise K,Ueno T,Yamanouchi M,Sawa N,Ohashi K,Fujii T,Takaichi K,Ubara Y, Cryoglobulinemic vasculitis with primary Sjögren's syndrome: A case report. Modern rheumatology. 2018 May;
[PubMed PMID: 26743943]
Level 3 (low-level) evidence
[15]
Giuggioli D,Manfredi A,Colaci M,Manzini CU,Antonelli A,Ferri C, Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. Autoimmunity reviews. 2013 Sep;
[PubMed PMID: 23806565]
[16]
Horino T,Hamada-Ode K,Ichii O,Terada Y, Overlapping Syndrome of Systemic Scleroderma and Cryoglobulinemic Vasculitis. The American journal of medicine. 2019 Jun;
[PubMed PMID: 30831066]
[17]
Nozawa K,Kaneko H,Itoh T,Katsura Y,Noguchi M,Suzuki F,Takasaki Y,Ogawa H,Takamori K,Sekigawa I, Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome. Rare tumors. 2009 Dec 28;
[PubMed PMID: 21139921]
[19]
Ramos-Casals M,Muñoz S,Medina F,Jara LJ,Rosas J,Calvo-Alen J,Brito-Zerón P,Forns X,Sánchez-Tapias JM, Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). The Journal of rheumatology. 2009 Jul;
[PubMed PMID: 19369460]
Level 3 (low-level) evidence
[20]
Gatta A,Giannini C,Lampertico P,Pontisso P,Quarta S,Zignego AL,Atzeni F,Sarzi-Puttini P, Hepatotropic viruses: new insights in pathogenesis and treatment. Clinical and experimental rheumatology. 2008 Jan-Feb;
[PubMed PMID: 18570752]
[21]
Payet J,Livartowski J,Kavian N,Chandesris O,Dupin N,Wallet N,Karras A,Salliot C,Suarez F,Avet-Loiseau H,Alyanakian MA,Nawakil CA,Park S,Tamburini J,Roux C,Bouscary D,Sparsa L, Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature. Leukemia
[PubMed PMID: 22385269]
Level 3 (low-level) evidence
[22]
Pawlotsky JM,Ben Yahia M,Andre C,Voisin MC,Intrator L,Roudot-Thoraval F,Deforges L,Duvoux C,Zafrani ES,Duval J, Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology (Baltimore, Md.). 1994 Apr;
[PubMed PMID: 8138255]
Level 2 (mid-level) evidence
[23]
Strait RT,Posgai MT,Mahler A,Barasa N,Jacob CO,Köhl J,Ehlers M,Stringer K,Shanmukhappa SK,Witte D,Hossain MM,Khodoun M,Herr AB,Finkelman FD, IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature. 2015 Jan 22;
[PubMed PMID: 25363774]
[24]
Gragnani L,Piluso A,Giannini C,Caini P,Fognani E,Monti M,Petrarca A,Ranieri J,Razzolini G,Froio V,Laffi G,Zignego AL, Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis and rheumatism. 2011 May;
[PubMed PMID: 21538321]
[25]
Sansonno D,Cornacchiulo V,Iacobelli AR,Di Stefano R,Lospalluti M,Dammacco F, Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology (Baltimore, Md.). 1995 Feb;
[PubMed PMID: 7843698]
[26]
Ferri C,Mascia MT, Cryoglobulinemic vasculitis. Current opinion in rheumatology. 2006 Jan;
[PubMed PMID: 16344620]
Level 3 (low-level) evidence
[27]
Levine JW,Gota C,Fessler BJ,Calabrese LH,Cooper SM, Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. The Journal of rheumatology. 2005 Jun;
[PubMed PMID: 15940780]
[28]
Landau DA,Saadoun D,Halfon P,Martinot-Peignoux M,Marcellin P,Fois E,Cacoub P, Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis and rheumatism. 2008 Feb;
[PubMed PMID: 18240235]
[29]
Berera S,Gomez A,Dholaria K,Arosemena LR,Ladino-Avellaneda MA,Barisoni L,Bhamidimarri KR, A Rare Case of Hepatitis C-Associated Cryoglobulinemic Duodenal Vasculitis. ACG case reports journal. 2016 Aug;
[PubMed PMID: 27807586]
Level 3 (low-level) evidence
[30]
Bonacci M,Lens S,Mariño Z,Londoño MC,Rodriguez-Tajes S,Sánchez-Tapias JM,Ramos-Casals M,Hernández-Rodríguez J,Forns X, Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure. Gastroenterology. 2018 Aug;
[PubMed PMID: 29705529]
[31]
Visentini M,Fiorilli M,Casato M, Persistence of Pathogenic B-Cell Clones and Relapse of Cryoglobulinemic Vasculitis in HCV-Cured Patients. Gastroenterology. 2019 Jan;
[PubMed PMID: 30315773]
[32]
Hegazy MT,Allam WR,Hussein MA,Zoheir N,Quartuccio L,El-Khamisy SF,Ragab G, Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs. EBioMedicine. 2018 Sep;
[PubMed PMID: 30139628]
[33]
Kazandjieva J,Antonov D,Kamarashev J,Tsankov N, Acrally distributed dermatoses: Vascular dermatoses (purpura and vasculitis). Clinics in dermatology. 2017 Jan - Feb;
[PubMed PMID: 27938815]
[34]
Agnello V,Chung RT,Kaplan LM, A role for hepatitis C virus infection in type II cryoglobulinemia. The New England journal of medicine. 1992 Nov 19;
[PubMed PMID: 1383822]
[35]
Agnello V,Abel G, Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis and rheumatism. 1997 Nov;
[PubMed PMID: 9365090]
[36]
Spatola L,Generali E,Angelini C,Badalamenti S,Selmi C, HCV-negative mixed cryoglobulinemia and kidney involvement: in-depth review on physiopathological and histological bases. Clinical and experimental medicine. 2018 Nov;
[PubMed PMID: 29956004]
[37]
Matignon M,Cacoub P,Colombat M,Saadoun D,Brocheriou I,Mougenot B,Roudot-Thoraval F,Vanhille P,Moranne O,Hachulla E,Hatron PY,Fermand JP,Fakhouri F,Ronco P,Plaisier E,Grimbert P, Clinical and morphologic spectrum of renal involvement in patients with mixed cryoglobulinemia without evidence of hepatitis C virus infection. Medicine. 2009 Nov;
[PubMed PMID: 19910748]
[38]
Retamozo S,Díaz-Lagares C,Bosch X,Bové A,Brito-Zerón P,Gómez ME,Yagüe J,Forns X,Cid MC,Ramos-Casals M, Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients. Medicine. 2013 Sep;
[PubMed PMID: 23974248]
[39]
Martin-Bouyer G, [Data concerning venereal diseases in metropolitan France for the year 1966]. Bulletin de l'Institut national de la sante et de la recherche medicale. 1967 Sep-Oct;
[PubMed PMID: 5632353]
[40]
Sanmugarajah J,Hussain S,Schwartz JM,Friedman S, Monoclonal cryoglobulinemia with extensive gangrene of all four extremities--a case report. Angiology. 2000 May;
[PubMed PMID: 10826861]
Level 3 (low-level) evidence
[41]
Meltzer M,Franklin EC,Elias K,McCluskey RT,Cooper N, Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. The American journal of medicine. 1966 Jun;
[PubMed PMID: 4956871]
[42]
Ferri C,Sebastiani M,Giuggioli D,Cazzato M,Longombardo G,Antonelli A,Puccini R,Michelassi C,Zignego AL, Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Seminars in arthritis and rheumatism. 2004 Jun;
[PubMed PMID: 15190522]
[43]
Ammendola A,Sampaolo S,Ambrosone L,Ammendola E,Ciccone G,Migliaresi S,Di Iorio G, Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle
[PubMed PMID: 15515001]
[44]
Cacoub P,Saadoun D,Limal N,Léger JM,Maisonobe T, Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS (London, England). 2005 Oct;
[PubMed PMID: 16251808]
[45]
Casato M,Saadoun D,Marchetti A,Limal N,Picq C,Pantano P,Galanaud D,Cianci R,Duhaut P,Piette JC,Fiorilli M,Cacoub P, Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. The Journal of rheumatology. 2005 Mar;
[PubMed PMID: 15742440]
Level 2 (mid-level) evidence
[46]
Cavalli G,Berti A,Fragasso G,De Cobelli F, Hypertrophic cardiomyopathy secondary to hepatitis C virus-related vasculitis. Journal of cardiovascular medicine (Hagerstown, Md.). 2016 Dec;
[PubMed PMID: 24979124]
[47]
De Vita S, Treatment of mixed cryoglobulinemia: a rheumatology perspective. Clinical and experimental rheumatology. 2011 Jan-Feb;
[PubMed PMID: 21586203]
Level 3 (low-level) evidence
[48]
Terrier B,Krastinova E,Marie I,Launay D,Lacraz A,Belenotti P,de Saint-Martin L,Quemeneur T,Huart A,Bonnet F,Le Guenno G,Kahn JE,Hinschberger O,Rullier P,Diot E,Lazaro E,Bridoux F,Zénone T,Carrat F,Hermine O,Léger JM,Mariette X,Senet P,Plaisier E,Cacoub P, Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 2012 Jun 21;
[PubMed PMID: 22474249]
Level 3 (low-level) evidence
[49]
Koukoulaki M,Abeygunasekara SC,Smith KG,Jayne DR, Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005 Jan;
[PubMed PMID: 15632353]
[50]
Mukhtyar C,Guillevin L,Cid MC,Dasgupta B,de Groot K,Gross W,Hauser T,Hellmich B,Jayne D,Kallenberg CG,Merkel PA,Raspe H,Salvarani C,Scott DG,Stegeman C,Watts R,Westman K,Witter J,Yazici H,Luqmani R, EULAR recommendations for the management of primary small and medium vessel vasculitis. Annals of the rheumatic diseases. 2009 Mar;
[PubMed PMID: 18413444]
[51]
Ostojic P, Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil. Rheumatology international. 2014 Jan;
[PubMed PMID: 23271426]
[52]
Cacoub P,Si Ahmed SN,Ferfar Y,Pol S,Thabut D,Hezode C,Alric L,Comarmond C,Ragab G,Quartuccio L,Hegazy M,Poynard T,Resche Rigon M,Saadoun D, Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2019 Feb;
[PubMed PMID: 29857143]
[53]
Saadoun D,Thibault V,Si Ahmed SN,Alric L,Mallet M,Guillaud C,Izzedine H,Plaisier A,Fontaine H,Costopoulos M,Le Garff-Tavernier M,Hezode C,Pol S,Musset L,Poynard T,Cacoub P, Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Annals of the rheumatic diseases. 2016 Oct;
[PubMed PMID: 26567178]
[54]
Taha R,El-Haddad H,Almuallim A,Alshaiki F,Obaid E,Almoallim H, Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomenon. Open access rheumatology : research and reviews. 2017;
[PubMed PMID: 29290695]
Level 1 (high-level) evidence
[55]
Dammacco F,Tucci FA,Lauletta G,Gatti P,De Re V,Conteduca V,Sansonno S,Russi S,Mariggiò MA,Chironna M,Sansonno D, Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood. 2010 Jul 22;
[PubMed PMID: 20308602]
[56]
Saadoun D,Resche Rigon M,Sene D,Terrier B,Karras A,Perard L,Schoindre Y,Coppéré B,Blanc F,Musset L,Piette JC,Rosenzwajg M,Cacoub P, Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010 Jul 22;
[PubMed PMID: 20439619]
[57]
Sneller MC,Hu Z,Langford CA, A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis and rheumatism. 2012 Mar;
[PubMed PMID: 22147444]
Level 1 (high-level) evidence
[58]
De Vita S,Quartuccio L,Isola M,Mazzaro C,Scaini P,Lenzi M,Campanini M,Naclerio C,Tavoni A,Pietrogrande M,Ferri C,Mascia MT,Masolini P,Zabotti A,Maset M,Roccatello D,Zignego AL,Pioltelli P,Gabrielli A,Filippini D,Perrella O,Migliaresi S,Galli M,Bombardieri S,Monti G, A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis and rheumatism. 2012 Mar;
[PubMed PMID: 22147661]
Level 1 (high-level) evidence
[59]
Sise ME,Bloom AK,Wisocky J,Lin MV,Gustafson JL,Lundquist AL,Steele D,Thiim M,Williams WW,Hashemi N,Kim AY,Thadhani R,Chung RT, Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology (Baltimore, Md.). 2016 Feb;
[PubMed PMID: 26474537]
[60]
Wen J,Xu F,Li M,Zhou Q,Qu W,Liu Y,Su J,Hu H, Type I cryoglobulinemic vasulitis with eosinophilia: A case report and literature review. Medicine. 2019 Jul;
[PubMed PMID: 31305439]
Level 3 (low-level) evidence
[61]
Ramirez GA,Campochiaro C,Salmaggi C,Pagliula G,D'Aliberti T,Marcatti M,Tresoldi M,Praderio L, Bortezomib in type I cryoglobulinemic vasculitis: are we acting too late? Internal medicine (Tokyo, Japan). 2015;
[PubMed PMID: 25948361]
[62]
Liu XH,Liu MX,Jin F,Zhang M,Zhang L, Concomitant cryoglobulinemic vasculitis and cold agglutinin disease successfully treated with bortezomib: A case report. Medicine. 2019 Jan;
[PubMed PMID: 30681592]
Level 3 (low-level) evidence
[63]
Spizzo G,Mitterer M,Gunsilius E, Bortezomib for the treatment of refractory Type-1 cryoglobulinaemia. British journal of haematology. 2010 Jul;
[PubMed PMID: 20346005]
[64]
Mazzaro C,Dal Maso L,Urraro T,Mauro E,Castelnovo L,Casarin P,Monti G,Gattei V,Zignego AL,Pozzato G, Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2016 Jul;
[PubMed PMID: 27106525]
[65]
Pasquet F,Combarnous F,Macgregor B,Coppere B,Mausservey C,Ninet J,Hot A, Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. Journal of medical case reports. 2012 Jan 27;
[PubMed PMID: 22284897]
Level 3 (low-level) evidence
[66]
Oykhman P,Hamilton MA,Aaron SL, Multiorgan Failure From Cryoglobulinemic Vasculitis Following Intravenous Immunoglobulin Replacement Therapy. Journal of clinical rheumatology : practical reports on rheumatic
[PubMed PMID: 27870771]
[67]
Chandesris MO,Gayet S,Schleinitz N,Doudier B,Harlé JR,Kaplanski G, Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. Rheumatology (Oxford, England). 2004 Apr;
[PubMed PMID: 15024144]
[68]
Bartolucci P,Ramanoelina J,Cohen P,Mahr A,Godmer P,Le Hello C,Guillevin L, Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford, England). 2002 Oct;
[PubMed PMID: 12364631]
Level 3 (low-level) evidence
[69]
Della Rossa A,Marchi F,Catarsi E,Tavoni A,Bombardieri S, Mixed cryoglobulinemia and mortality: a review of the literature. Clinical and experimental rheumatology. 2008 Sep-Oct;
[PubMed PMID: 19026151]
[70]
Guillevin L,Lhote F,Gayraud M,Cohen P,Jarrousse B,Lortholary O,Thibult N,Casassus P, Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine. 1996 Jan;
[PubMed PMID: 8569467]
[71]
Terrier B,Semoun O,Saadoun D,Sène D,Resche-Rigon M,Cacoub P, Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis and rheumatism. 2011 Jun;
[PubMed PMID: 21400476]
[72]
Calle Toro JS,Davalos DM,Charry JD,Arrunategi AM,Tobon G, Hepatic and Mesenteric Vasculitis as Presenting Manifestation of Mixed Cryoglobulinemia Related to Chronic Hepatitis C Virus Infection in a Female Patient. Journal of clinical rheumatology : practical reports on rheumatic
[PubMed PMID: 27219310]
[73]
Terrier B,Carrat F,Krastinova E,Marie I,Launay D,Lacraz A,Belenotti P,de Saint Martin L,Quemeneur T,Huart A,Bonnet F,Le Guenno G,Kahn JE,Hinschberger O,Rullier P,Hummel A,Diot E,Pagnoux C,Lzaro E,Bridoux F,Zenone T,Hermine O,Leger JM,Mariette X,Senet P,Plaisier E,Cacoub P, Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey. Annals of the rheumatic diseases. 2013 Mar;
[PubMed PMID: 22586172]
Level 3 (low-level) evidence
[74]
Zaidan M,Terrier B,Pozdzik A,Frouget T,Rioux-Leclercq N,Combe C,Lepreux S,Hummel A,Noël LH,Marie I,Legallicier B,François A,Huart A,Launay D,Kaplanski G,Bridoux F,Vanhille P,Makdassi R,Augusto JF,Rouvier P,Karras A,Jouanneau C,Verpont MC,Callard P,Carrat F,Hermine O,Léger JM,Mariette X,Senet P,Saadoun D,Ronco P,Brochériou I,Cacoub P,Plaisier E, Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. Journal of the American Society of Nephrology : JASN. 2016 Apr;
[PubMed PMID: 26260165]
[75]
Sidana S,Rajkumar SV,Dispenzieri A,Lacy MQ,Gertz MA,Buadi FK,Hayman SR,Dingli D,Kapoor P,Gonsalves WI,Go RS,Hwa YL,Leung N,Fonder AL,Hobbs MA,Zeldenrust SR,Russell SJ,Lust JA,Kyle RA,Kumar SK, Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia. American journal of hematology. 2017 Jul;
[PubMed PMID: 28370486]
[76]
Monti G,Pioltelli P,Saccardo F,Campanini M,Candela M,Cavallero G,De Vita S,Ferri C,Mazzaro C,Migliaresi S,Ossi E,Pietrogrande M,Gabrielli A,Galli M,Invernizzi F, Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Archives of internal medicine. 2005 Jan 10;
[PubMed PMID: 15642884]
Level 3 (low-level) evidence
[77]
Arandjelovic S,Bonaci-Nikolic B,Peric-Popadic A,Tomic-Spiric V,Bolpacic J,Raskovic S,Andrejevic S, HCV related severe cryoglobulinemic vasculitis treated with plasma exchange and rituximab: case report and literature review. Journal of infection in developing countries. 2017 Jun 1;
[PubMed PMID: 30943182]
Level 3 (low-level) evidence
[78]
Odish M,Beben T,Daniels LB, False-positive Troponin I Assay elevation due to occult Mixed Cryoglobulinemic Vasculitis. Reviews in cardiovascular medicine. 2018 Jun 30;
[PubMed PMID: 31032606]